SK282147B6 - Aerosólový suspenzačný prípravok a jeho použitie - Google Patents

Aerosólový suspenzačný prípravok a jeho použitie Download PDF

Info

Publication number
SK282147B6
SK282147B6 SK253-99A SK25399A SK282147B6 SK 282147 B6 SK282147 B6 SK 282147B6 SK 25399 A SK25399 A SK 25399A SK 282147 B6 SK282147 B6 SK 282147B6
Authority
SK
Slovakia
Prior art keywords
ethanol
aerosol
mometasone furoate
drug
oleic acid
Prior art date
Application number
SK253-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK25399A3 (en
Inventor
Julianne Berry
Joel A. Sequeira
Imtiaz A. Chaudry
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SK25399A3 publication Critical patent/SK25399A3/sk
Publication of SK282147B6 publication Critical patent/SK282147B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
SK253-99A 1996-08-29 1997-08-26 Aerosólový suspenzačný prípravok a jeho použitie SK282147B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70536896A 1996-08-29 1996-08-29
PCT/US1997/014708 WO1998008519A1 (en) 1996-08-29 1997-08-26 Chlorofluorocarbon-free mometasone furoate aerosol formulations

Publications (2)

Publication Number Publication Date
SK25399A3 SK25399A3 (en) 1999-12-10
SK282147B6 true SK282147B6 (sk) 2001-11-06

Family

ID=24833161

Family Applications (1)

Application Number Title Priority Date Filing Date
SK253-99A SK282147B6 (sk) 1996-08-29 1997-08-26 Aerosólový suspenzačný prípravok a jeho použitie

Country Status (31)

Country Link
EP (1) EP0927037B1 (de)
JP (1) JP3264496B2 (de)
KR (1) KR100316358B1 (de)
CN (1) CN1162157C (de)
AR (1) AR008309A1 (de)
AT (1) ATE202936T1 (de)
AU (1) AU719079B2 (de)
BR (1) BR9711445A (de)
CA (1) CA2263905C (de)
CO (1) CO4900027A1 (de)
CZ (1) CZ294064B6 (de)
DE (1) DE69705628T2 (de)
DK (1) DK0927037T3 (de)
ES (1) ES2159148T3 (de)
GR (1) GR3036674T3 (de)
HK (1) HK1018206A1 (de)
HU (1) HU227915B1 (de)
ID (1) ID18137A (de)
IL (1) IL128714A (de)
MY (1) MY117377A (de)
NO (1) NO322528B1 (de)
NZ (1) NZ334112A (de)
PE (1) PE100198A1 (de)
PL (1) PL189036B1 (de)
PT (1) PT927037E (de)
SA (1) SA97180339B1 (de)
SK (1) SK282147B6 (de)
TR (1) TR199900379T2 (de)
TW (1) TW475901B (de)
WO (1) WO1998008519A1 (de)
ZA (1) ZA977668B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
CA2468958C (en) 2001-12-19 2012-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
MXPA05002060A (es) * 2002-08-23 2005-06-08 Schering Corp Composiciones farmaceuticas.
EP1878664B1 (de) * 2002-08-27 2011-03-30 Schering Corporation Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis
EP1925293A3 (de) * 2003-10-20 2010-01-13 Schering Corporation Pharmazeutische Aerosol-Zusammensetzungen
US20050136009A1 (en) * 2003-10-20 2005-06-23 Schering Corporation Pharmaceutical compositions
EP2117504A1 (de) * 2007-02-09 2009-11-18 Schering Corporation Stabile pharmazeutische wirkstoff-aerosole
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物
CN107961217B (zh) * 2016-10-18 2021-06-29 天津金耀集团有限公司 一种糠酸莫米松气雾剂组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
PT656207E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
JPH06508149A (ja) * 1991-06-10 1994-09-14 シェリング・コーポレーション クロロフルオロカーボン不含エーロゾル製剤
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

Also Published As

Publication number Publication date
HUP9902675A2 (hu) 2000-01-28
WO1998008519A1 (en) 1998-03-05
KR100316358B1 (ko) 2001-12-12
PL331828A1 (en) 1999-08-02
ID18137A (id) 1998-03-05
CA2263905A1 (en) 1998-03-05
NO990956L (no) 1999-04-28
PL189036B1 (pl) 2005-06-30
KR20000035879A (ko) 2000-06-26
HK1018206A1 (en) 1999-12-17
DE69705628D1 (de) 2001-08-16
MY117377A (en) 2004-06-30
CA2263905C (en) 2002-05-14
NO990956D0 (no) 1999-02-26
IL128714A0 (en) 2000-01-31
PE100198A1 (es) 1999-01-11
SA97180339B1 (ar) 2006-01-31
AU4232997A (en) 1998-03-19
TW475901B (en) 2002-02-11
CZ294064B6 (cs) 2004-09-15
CZ63299A3 (cs) 1999-07-14
JP3264496B2 (ja) 2002-03-11
AU719079B2 (en) 2000-05-04
TR199900379T2 (xx) 1999-05-21
NZ334112A (en) 2000-07-28
BR9711445A (pt) 1999-08-24
ATE202936T1 (de) 2001-07-15
CO4900027A1 (es) 2000-03-27
IL128714A (en) 2003-05-29
ES2159148T3 (es) 2001-09-16
SK25399A3 (en) 1999-12-10
GR3036674T3 (en) 2001-12-31
AR008309A1 (es) 1999-12-29
EP0927037B1 (de) 2001-07-11
ZA977668B (en) 1998-02-26
JP2000503673A (ja) 2000-03-28
DE69705628T2 (de) 2002-05-08
HUP9902675A3 (en) 2000-02-28
CN1233960A (zh) 1999-11-03
PT927037E (pt) 2001-10-31
DK0927037T3 (da) 2001-09-24
NO322528B1 (no) 2006-10-16
EP0927037A1 (de) 1999-07-07
CN1162157C (zh) 2004-08-18
HU227915B1 (en) 2012-05-29

Similar Documents

Publication Publication Date Title
EP1014943B1 (de) Medizinische aerosolformulierungen
US6068832A (en) Chlorofluorocarbon-free mometasone furoate aerosol formulations
RU2294737C2 (ru) Медицинские аэрозольные составы
US20100143269A1 (en) Pharmaceutical compositions for the treatment of asthma
AU2002313828A1 (en) Pharmaceutical compositions for the treatment of asthma
US20100095963A1 (en) Pharmaceutical compositions
JP6568511B2 (ja) 改善された医薬エアゾール製剤
SK282147B6 (sk) Aerosólový suspenzačný prípravok a jeho použitie
EP1785156B1 (de) Aerosolhaltiger pharmazeutischer Dosierinhalator
MXPA99001786A (en) Chlorofluorocarbon-free mometasone furoate aerosol formulations

Legal Events

Date Code Title Description
TC4A Change of owner's name

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, NJ, US

Effective date: 20121108

MK4A Patent expired

Expiry date: 20170826